Trillium Asset Management LLC Sells 502 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Trillium Asset Management LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 40,112 shares of the healthcare conglomerate’s stock after selling 502 shares during the quarter. Trillium Asset Management LLC’s holdings in UnitedHealth Group were worth $20,291,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. NewSquare Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $30,000. Promus Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the 3rd quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at approximately $40,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.9 %

Shares of NYSE UNH opened at $503.61 on Wednesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business has a fifty day simple moving average of $510.90 and a two-hundred day simple moving average of $548.54. The firm has a market cap of $460.66 billion, a PE ratio of 32.49, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.83 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.67%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on UNH shares. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Barclays dropped their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. KeyCorp reiterated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.